Is there an indirect way to invest in Merus N.V.?

Direct listed exposure is available, so an indirect proxy is usually unnecessary.

Does Merus N.V. have a stock symbol?

The stock symbol is MRUS on NASDAQ.

Merus N.V.

Status: Publicly traded

Direct answer

Merus N.V. is publicly traded on NASDAQ under the ticker MRUS.

Merus N.V. is a clinical-stage immuno-oncology firm based in the Netherlands, specializing in the discovery and advancement of bispecific antibody therapies. Established in 2003, the company maintains its headquarters in Utrecht. Its robust pipeline of bispecific antibody candidates includes Zenocutuzumab (MCLA-128), which is currently undergoing Phase 2 clinical trials for the treatment of patients with metastatic...

Can you invest in Merus N.V.?

Yes. Merus N.V. is publicly traded on NASDAQ under the ticker MRUS.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Merus N.V.

Detailed equity research is provided by MarketSnap.